RxDoctor Payments Data

Chelsey Sotomayor, PA

Medical · Reading, PANPI 1740567353

Payments from drug & device makers

$2,159in general payments, 2019–2025

Across 101 payments — averaging $21.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$315
  • EMD Serono, Inc.$201
  • Amneal Pharmaceuticals LLC$155
  • Acadia Pharmaceuticals Inc$109
  • Otsuka America Pharmaceutical, Inc.$84
  • Neurocrine Biosciences, Inc.$84
  • plus $1K from 30 others

What the payments were for

  • Food & beverage$2,14599%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,159 in reported general payments places this provider in the 80th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$13,380
Medicare patients
75
Services billed
121

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Emgality PenGalcanezumab-Gnlm164$126,504
UbrelvyUbrogepant73$88,712
Nurtec OdtRimegepant Sulfate46$45,284
QuliptaAtogepant23$24,498
Ajovy AutoinjectorFremanezumab-Vfrm21$16,957
Aimovig AutoinjectorErenumab-Aooe19$13,969
Topiramate ErTopiramate14$11,705
Sumatriptan19$2,874
Lacosamide25$1,546
Donepezil Hcl32$1,539
Pregabalin41$1,400
RizatriptanRizatriptan Benzoate72$1,014
Memantine Hcl63$1,007
Gabapentin41$998
Candesartan Cilexetil24$856

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy, Qulipta$315$113,21096 claims
PfizerNurtec Odt$28$45,28446 claims
Upsher-smith Laboratories LLCTopiramate$21$84575 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Reading

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →